Cytokinetics (CYTK) Assets (2010 - 2026)
Cytokinetics (CYTK) posted Assets of $1.92 billion for Q2 2026, up 57.0% from $1.23 billion a year earlier and up 51.1% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics' Assets came in at $1.42 billion, up 1.6% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
- In prior years, Cytokinetics' Assets was $1.4 billion in FY2024 (+70.0%), $824.32 million in FY2023 (-18.8%), $1.01 billion in FY2022 (+20.6%) and $841.32 million in FY2021 (+57.6%).
- The Q2 2026 figure stands as the highest quarterly Assets in data going back to Q4 2010.
- On a year-over-year basis, Assets has increased in each of the last three quarters, with growth averaging 32.5% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2024, with growth of 95.4%; the weakest was Q3 2023, with a decline of 31.2%.
- According to Business Quant data, Assets for the three prior quarters was $1.27 billion (Q1 2026), $1.42 billion (Q4 2025) and $1.44 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn | 1.92 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.42 Bn |
| Sep 30, 2025 | 1.44 Bn |
| Jun 30, 2025 | 1.23 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 1.44 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 808.08 Mn |
| Dec 31, 2023 | 824.32 Mn |
| Sep 30, 2023 | 740.61 Mn |
| Jun 30, 2023 | 779.90 Mn |
| Mar 31, 2023 | 889.82 Mn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 771.72 Mn |
| Mar 31, 2022 | 856.25 Mn |
| Dec 31, 2021 | 841.32 Mn |
| Sep 30, 2021 | 827.54 Mn |
API Access
Cytokinetics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();